ODESSA, FLORIDA, Jan. 19, 2024/PRNewswire/ — Belmar Pharma Solutions celebrated the grand opening of their newest Compounding Center of Excellence – Belmar Pharmacy, in Odessa, Florida, on Friday, January 19, 2024. This new $15 million, 25,000 sq. ft. state-of-the-art sterile compounding facility provides professional employment for 150 highly trained, on-site, clinical team members. Belmar Pharmacy was designed to exceed compounding industry standards, and is prepared for the future of compounding. The pharmacy upholds the strictest state and federal regulations, all with the health and safety of patients at the forefront of the design.
“We are the largest national compounding pharmacy organization focused on hormone health and wellness,” said Rob Kilgore, Chief Executive Officer. “With seven compounding facilities across the country, we’re on track to support more than 500,000 patients in 2024 with both sterile and non-sterile personalized medications.”
The organization’s sole focus is on hormone health and wellness, ensuring that they are experts in the products their pharmacists and clinicians produce for prescribers and patients across the country.
About Belmar Pharma Solutions
Belmar Pharma Solutions is the nation’s leading compounding pharmacy organization focusing on hormone health and longevity. Established in 1985, the company is accredited by the National Association of Boards of Pharmacy, certified by LegitScript and is a member of the Alliance for Pharmacy Compounding. Headquartered in Golden, CO, Belmar Pharma Solutions operates 503A compounding pharmacies in CO, AZ., FL., KS., UT and WI. and 503B FDA-registered outsourcing facilities in CO.
For more information about Belmar Pharma Solutions, visit BelmarPharmaSolutions.com and follow us on LinkedIn.
